Meridian Bioscience (VIVO) Reports In-Line Q3 EPS, Miss on Revenues; Affirms Fiscal 2018 Guidance
Go back to Meridian Bioscience (VIVO) Reports In-Line Q3 EPS, Miss on Revenues; Affirms Fiscal 2018 Guidance| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 4.59 +0.37 (8.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.22 | 52 Week High | $21.49 | |||
| Open | $4.23 | 52 Week Low | $15.75 | |||
| Day High | $4.80 | P/E | 5.22 | |||
| Day Low | $4.20 | EPS | $0.88 | |||
| Volume | 1,127,956 | |||||
